Immunohistochemical scores at baseline and three months after HDC + ASCT for responders and non-responders
| Responders (n = 5) | Non-responders (n = 2) | |||
|---|---|---|---|---|
| Baseline | 3 Months | Baseline | 3 Months | |
| CD3 | 3.00 | 1.60 | 0 | 0.50 |
| CD4 | 2.60 | 1.20 | 0 | 0.50 |
| CD8 | 2.00 | 2.00 | 0 | 0.50 |
| CD25 | 2.00 | 0.60 | 0 | 0 |
| CD27 | 3.00 | 1.00 | 0 | 0.50 |
| CD45RA | 2.60 | 0.60 | 0 | 0.50 |
| CD45RB | 3.20 | 2.00 | 0 | 1.00 |
| CD45RO | 3.40 | 1.80 | 0 | 1.00 |
| CD19 | 1.60 | 0.60 | 2.00 | 0 |
| CD38 | 3.00 | 2.20 | 2.00 | 2.00 |
| CD68 lining | 1.80 | 2.40 | 0.50 | 1.50 |
| CD55 lining | 2.60 | 3.80 | 1.50 | 1.50 |
| CD68 sublining | 2.20 | 2.00 | 0.50 | 0.50 |
| HLA-DR | 2.60 | 2.60 | 0 | 1.50 |
| CD62L | 0.60 | 1.20 | 0 | 0.50 |
| CD62E | 0.40 | 0.20 | 1.00 | 0 |
| CD56 | 2.20 | 1.80 | 1.50 | 3.00 |
| IL1β | 1.00 | 0.60 | 0 | 4.0 |
| TNFα | 2.1 | 1.8 | 1.00 | 3.25 |
| IFNγ | 2.00 | 2.60 | 1.00 | 2.00 |
| IL12 | 2.00 | 1.20 | 2.00 | 3.50 |
| IL10 | 1.20 | 2.30 | 1.50 | 3.50 |